Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 3801 - 3900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 3801 | 25047772 |
LK |
24 | 1 |
Overdose, |
||||
OLANZAPINE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 3802 | 25048052 |
CA |
2 | |
Immunodeficiency, Joint swelling, Hypersensitivity, Exposure during pregnancy, Hepatic enzyme increased, Food allergy, Overdose, Intentional product misuse, Product use issue, Infusion related reaction, Hyperhidrosis, Prescribed overdose, Pain, Headache, Hypertension, Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, PROGESTERONE, CLONIDINE, TOCILIZUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PANTOPRAZOLE, CYCLOBENZAPRINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, BUPROPION, ALBUTEROL SULFATE, ALBUTEROL, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3803 | 25048159 |
US |
2 | |
Encephalopathy, Seizure, Cardiac arrest, Circulatory collapse, Shock, Overdose, |
||||
BUPROPION, |
||||
| 3804 | 25038899 |
AU |
||
Seizure, Delirium, Electrocardiogram QRS complex, Somnolence, Toxicity to various agents, Overdose, |
||||
DICLOFENAC, DICLOFENAC SODIUM, NAPROXEN, NAPROXEN SODIUM, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 3805 | 25038925 |
GB |
88 | 2 |
Arthritis bacterial, Streptococcal sepsis, Sepsis, Streptococcal infection, Arthralgia, Product use in unapproved indication, Overdose, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 3806 | 25039096 |
US |
2 | |
Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 3807 | 25040116 |
US |
58 | 2 |
Acute myocardial infarction, Acute respiratory failure, Autoimmune hepatitis, Chronic hepatic failure, Transaminases increased, Anaemia, Abdominal pain, Asthenia, Jaundice, Toxicity to various agents, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3808 | 25040268 |
US |
34 | 1 |
Mitral valve incompetence, Overdose, |
||||
FENFLURAMINE, FENFLURAMINE, |
||||
| 3809 | 25040272 |
IT |
47 | 1 |
Drug abuse, Intentional self-injury, Bradykinesia, Vomiting, Overdose, |
||||
ZOLPIDEM TARTRATE, |
||||
| 3810 | 25040320 |
US |
1 | |
Wrong technique in product usage process, Dehydration, Overdose, Device inappropriate shock delivery, Internal haemorrhage, Device malfunction, Device delivery system issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 3811 | 25040363 |
2 | ||
Non-cardiogenic pulmonary oedema, Overdose, Suicide attempt, Toxicity to various agents, |
||||
AMLODIPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 3812 | 25040364 |
21 | 1 | |
Non-cardiogenic pulmonary oedema, Toxicity to various agents, Overdose, Incorrect dose administered, |
||||
AMLODIPINE, |
||||
| 3813 | 25040734 |
US |
32 | 2 |
Seizure, Product use issue, Overdose, |
||||
BRIVARACETAM, |
||||
| 3814 | 25040814 |
CA |
30 | 1 |
Toxicity to various agents, Overdose, |
||||
AMPHETAMINE, CAFFEINE, GABAPENTIN, OLANZAPINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, FENTANYL, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 3815 | 25041063 |
IT |
15 | 2 |
Death, Toxicity to various agents, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, COLCHICINE, OLANZAPINE, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 3816 | 25041109 |
US |
||
Overdose, |
||||
INCOBOTULINUMTOXINA, |
||||
| 3817 | 25042161 |
ES |
52 | 2 |
Suicide attempt, Depressed level of consciousness, Drug interaction, Overdose, |
||||
FLUOXETINE HYDROCHLORIDE, PREGABALIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CLONAZEPAM, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 3818 | 25042185 |
FR |
48 | 1 |
Hepatitis toxic, Renal failure, Overdose, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, ISONIAZID, ISONIAZID, ISONIAZID, ISONIAZID, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, IVERMECTIN, IVERMECTIN, IVERMECTIN, IVERMECTIN, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, ENTECAVIR, ENTECAVIR ANHYDROUS, ENTECAVIR, ENTECAVIR ANHYDROUS, ENTECAVIR, ENTECAVIR ANHYDROUS, ENTECAVIR, ENTECAVIR ANHYDROUS, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MORPHINE, MORPHINE, MORPHINE, MORPHINE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, |
||||
| 3819 | 25042581 |
BR |
1 | |
Depression, Somnolence, Malaise, Drug ineffective, Drug interaction, Off label use, Overdose, Wrong schedule, Product packaging quantity issue, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ZIPRASIDONE, ZIPRASIDONE MESYLATE, ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE, ZIPRASIDONE MESYLATE, ZIPRASIDONE HYDROCHLORIDE, |
||||
| 3820 | 25042799 |
US |
82 | 2 |
Gout, Overdose, |
||||
MINOXIDIL, |
||||
| 3821 | 25042826 |
US |
||
Near death experience, Overdose, Drug dependence, Emotional distress, Injury, General physical health deterioration, Prescription drug used without a prescription, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, MORPHINE SULFATE, |
||||
| 3822 | 25042847 |
US |
1 | |
Overdose, |
||||
MORPHINE SULFATE, |
||||
| 3823 | 25042981 |
US |
71 | 2 |
Loss of consciousness, Fall, Subarachnoid haemorrhage, Overdose, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 3824 | 25043155 |
US |
37 | 2 |
Hospitalisation, Overdose, Unevaluable event, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 3825 | 25034070 |
FR |
31 | 2 |
Device dislocation, Pregnancy with implant contraceptive, Unintended pregnancy, Weight decreased, Complication associated with device, Implant site scar, Incorrect product administration duration, Overdose, Inappropriate schedule of product administration, |
||||
ETONOGESTREL, ETONOGESTREL, |
||||
| 3826 | 25034194 |
ES |
||
Accidental death, Intentional product misuse, Overdose, Suicide attempt, |
||||
PROPOFOL, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, QUETIAPINE FUMARATE, QUETIAPINE, FENTANYL, |
||||
| 3827 | 25034547 |
ZA |
2 | |
Suicide attempt, Non-cardiogenic pulmonary oedema, Respiratory distress, Nosocomial infection, Hypocalcaemia, Metabolic acidosis, Sinus tachycardia, Toxicity to various agents, Overdose, |
||||
AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3828 | 25034836 |
US |
2 | |
Dyspnoea, Incorrect dose administered by device, Product dose omission issue, Overdose, Device defective, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 3829 | 25034923 |
ZA |
2 | |
Overdose, Non-cardiogenic pulmonary oedema, Hypocalcaemia, |
||||
AMLODIPINE BESYLATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 3830 | 25034927 |
JP |
2 | |
Toxicity to various agents, Labelled drug-food interaction medication error, Drug abuse, Overdose, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ZOLPIDEM TARTRATE, CHLORPHENIRAMINE MALEATE, OLANZAPINE, ALPRAZOLAM, ASENAPINE MALEATE, CAFFEINE, CLONAZEPAM, LORAZEPAM, NORTRIPTYLINE HYDROCHLORIDE, PHENOBARBITAL, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, ROPINIROLE HYDROCHLORIDE, SUVOREXANT, TRIAZOLAM, METHYLPHENIDATE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, |
||||
| 3831 | 25035003 |
CO |
34 | 1 |
Overdose, Malaise, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 3832 | 25035158 |
US |
2 | |
Drug level increased, Accidental exposure to product, Overdose, Encephalopathy, Seizure, Cardiac arrest, Brain death, Shock, |
||||
BUPROPION, |
||||
| 3833 | 25035176 |
JP |
2 | |
Cardiac arrest, Toxicity to various agents, Overdose, |
||||
LACOSAMIDE, |
||||
| 3834 | 25035186 |
FR |
77 | 2 |
Lactic acidosis, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 3835 | 25035634 |
28 | 2 | |
Rheumatoid arthritis, Overdose, Localised infection, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEVOTHYROXINE SODIUM, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, |
||||
| 3836 | 25035706 |
FR |
16 | 2 |
Hallucination, Hallucinations, mixed, Hyperkalaemia, Drug abuse, Confusional state, Sinus tachycardia, Cognitive disorder, Disorientation, Headache, Mydriasis, Speech disorder, Gamma-glutamyltransferase increased, Aspartate aminotransferase increased, Drug interaction, Wrong technique in product usage process, Toxicity to various agents, Overdose, Drug diversion, Intentional product misuse, Suicide attempt, Disorganised speech, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, SERTRALINE, SERTRALINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RISPERIDONE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, HYDROXYZINE, HYDROXYZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 3837 | 25035738 |
US |
28 | 2 |
Overdose, Headache, Dizziness, Nausea, Vomiting, Device infusion issue, Device infusion issue, Device infusion issue, Device wireless communication issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ENALAPRIL MALEATE, ENALAPRIL, TAMSULOSIN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, RAMIPRIL, DUTASTERIDE, KETAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ZOLPIDEM TARTRATE, MACITENTAN, CLONIDINE, KETOPROFEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIGOXIN, HYDROCHLOROTHIAZIDE, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AMITRIPTYLINE HYDROCHLORIDE, GABAPENTIN, |
||||
| 3838 | 25035769 |
CA |
||
Abdominal discomfort, Intentional product use issue, Overdose, |
||||
RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, AZATHIOPRINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, MINOCYCLINE, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, SULFASALAZINE, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, DESOGESTREL AND ETHINYL ESTRADIOL, NAPROXEN, NAPROXEN SODIUM, |
||||
| 3839 | 25035942 |
US |
||
Hospitalisation, Inappropriate schedule of product administration, Overdose, |
||||
ALBUTEROL SULFATE, |
||||
| 3840 | 25036093 |
US |
17 | 2 |
Nausea, Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TRANEXAMIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CAFFEINE, |
||||
| 3841 | 25036458 |
CN |
24 | 1 |
Overdose, Bradyphrenia, Psychomotor retardation, Loss of consciousness, Seizure, |
||||
CHLORPROMAZINE, CHLORPROMAZINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 3842 | 25036463 |
US |
81 | 1 |
Dandruff, Hair disorder, Overdose, Off label use, |
||||
| 3843 | 25037712 |
CA |
2 | |
Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Joint swelling, Pain, Infusion related reaction, Exposure during pregnancy, Intentional product misuse, Off label use, Overdose, Prescribed overdose, Product use issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, BUPROPION, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CLONIDINE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUCONAZOLE, FUROSEMIDE, GABAPENTIN, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ABATACEPT, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, TEMAZEPAM, RITUXIMAB, RITUXIMAB, SENNA LEAF, SENNOSIDES, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, BUPROPION HYDROCHLORIDE, |
||||
| 3844 | 25037820 |
CA |
||
Immunodeficiency, Pain, Hyperhidrosis, Exposure during pregnancy, Joint swelling, Hypertension, Food allergy, Infusion related reaction, Hepatic enzyme increased, Hypersensitivity, Headache, Off label use, Product use issue, Prescribed overdose, Intentional product misuse, Overdose, Dysphagia, |
||||
FLUCONAZOLE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE, PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ETANERCEPT, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, STANDARDIZED SENNA CONCENTRATE, PROGESTERONE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CYCLOBENZAPRINE, QUETIAPINE FUMARATE, QUETIAPINE, SENNA LEAF, SENNA LEAF, KETOPROFEN, ABATACEPT, ABATACEPT, CLONIDINE, CLONIDINE, CLONIDINE, NORTRIPTYLINE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, MONTELUKAST SODIUM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, RANITIDINE HYDROCHLORIDE, TEMAZEPAM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ALBUTEROL SULFATE, GABAPENTIN, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, SENNOSIDES, SENNOSIDES, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, SENNOSIDES, SENNA LEAF, SENNA, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, FUROSEMIDE, TEMAZEPAM, HYDROMORPHONE HYDROCHLORIDE, PSYLLIUM HUSK, INFLIXIMAB, BUPROPION, BUPROPION, BUPROPION, BUPROPION, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, DOLUTEGRAVIR SODIUM, |
||||
| 3845 | 25038049 |
US |
1 | |
Overdose, No adverse event, |
||||
FLOTUFOLASTAT F-18, |
||||
| 3846 | 25038052 |
US |
75 | 1 |
Overdose, No adverse event, |
||||
FLOTUFOLASTAT F-18, |
||||
| 3847 | 25038145 |
FR |
16 | 2 |
Cognitive disorder, Disorientation, Toxicity to various agents, Overdose, Drug abuse, Wrong technique in product usage process, Gamma-glutamyltransferase increased, Aspartate aminotransferase increased, Headache, Mydriasis, Hallucinations, mixed, Sinus tachycardia, Hyperkalaemia, Speech disorder, Drug interaction, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, SERTRALINE, SERTRALINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, RISPERIDONE, HYDROXYZINE, HYDROXYZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3848 | 25038545 |
US |
74 | 1 |
Asthma, Seasonal allergy, Influenza, Incorrect dose administered by device, Poor quality device used, Wrong technique in device usage process, Overdose, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 3849 | 25028986 |
US |
||
Product dispensing error, Overdose, Memory impairment, Fall, Dizziness, Dyspnoea, |
||||
BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, |
||||
| 3850 | 25029048 |
US |
75 | 2 |
Drug dose omission by device, Headache, Migraine, Overdose, |
||||
GALCANEZUMAB-GNLM, |
||||
| 3851 | 25029191 |
DE |
2 | |
Large intestine perforation, Diverticulitis, Overdose, Treatment noncompliance, |
||||
SEMAGLUTIDE, |
||||
| 3852 | 25029266 |
FR |
92 | 2 |
Acute kidney injury, Device related infection, Overdose, |
||||
| 3853 | 25029496 |
CA |
||
Death, Complication associated with device, Surgery, Product storage error, Inappropriate schedule of product administration, Overdose, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-RYVK, |
||||
| 3854 | 25030193 |
US |
2 | |
Dyspnoea, Anaemia, Osteoporosis, Product dose omission issue, Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, OXYGEN, 0XYGEN, FERROUS SULFATE, |
||||
| 3855 | 25030682 |
JP |
70 | 1 |
Product prescribing error, Overdose, |
||||
APREMILAST, APREMILAST, |
||||
| 3856 | 25030721 |
CA |
27 | 1 |
Skin laceration, Overdose, Fall, |
||||
QUETIAPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, |
||||
| 3857 | 25031426 |
ES |
1 | |
Non-cardiogenic pulmonary oedema, Drug interaction, Drug abuse, Toxicity to various agents, Intentional product misuse, Drug dependence, Overdose, Suicide attempt, Acute pulmonary oedema, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FENTANYL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PROPOFOL, CLONAZEPAM, ALPRAZOLAM, ZOLPIDEM TARTRATE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 3858 | 25032066 |
JP |
2 | 2 |
Overdose, |
||||
MIDODRINE HYDROCHLORIDE, |
||||
| 3859 | 25032180 |
US |
49 | 1 |
Overdose, Toxicity to various agents, |
||||
FENTANYL, GABAPENTIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), AMPHETAMINE, CARISOPRODOL, METHOCARBAMOL, METHOCARBAMOL TABLETS, |
||||
| 3860 | 25032257 |
HR |
||
Pallor, Drug withdrawal syndrome, Tremor, Overdose, Drug abuse, Incorrect route of product administration, |
||||
PREGABALIN, |
||||
| 3861 | 25032436 |
FR |
25 | 1 |
Asthenia, Vertigo, Palpitations, Nausea, Pruritus, Overdose, |
||||
| 3862 | 25032755 |
US |
81 | 1 |
Overdose, Adverse drug reaction, Gout, Product storage error, |
||||
GABAPENTIN, DUPILUMAB, |
||||
| 3863 | 25032823 |
US |
2 | |
Encephalopathy, Circulatory collapse, Cardiac arrest, Shock, Seizure, Overdose, |
||||
BUPROPION, |
||||
| 3864 | 25032838 |
US |
2 | |
Overdose, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 3865 | 25032844 |
US |
2 | |
Hospitalisation, Congenital anomaly, Overdose, Drug dependence, Coma, Learning disability, General physical health deterioration, Joint swelling, Gait disturbance, Ocular hyperaemia, Dysstasia, Dyspnoea, Hypertension, Anxiety, Peripheral swelling, |
||||
OXYCODONE HYDROCHLORIDE, MORPHINE SULFATE, |
||||
| 3866 | 25032869 |
JP |
64 | 1 |
Injection site pain, Alcoholic hangover, Nausea, Injection site haemorrhage, Feeling abnormal, Spinal X-ray abnormal, Insomnia, Nasopharyngitis, Injection site deformation, Injection site discolouration, Chest discomfort, Decreased appetite, Overdose, Injection site discomfort, Injection site pain, Feeling abnormal, Pyrexia, Dizziness, Malaise, Feeling abnormal, Feeling abnormal, Cardiac dysfunction, Diabetes mellitus, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 3867 | 25033067 |
EU |
1 | |
Acute pulmonary oedema, Non-cardiogenic pulmonary oedema, Intentional product misuse, Drug abuse, Drug interaction, Drug dependence, Toxicity to various agents, Overdose, Suicide attempt, |
||||
FENTANYL, FENTANYL, FENTANYL, FENTANYL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 3868 | 25033203 |
US |
2 | |
Overdose, |
||||
FENTANYL, |
||||
| 3869 | 25033964 |
US |
1 | |
Cardiac dysfunction, Overdose, Nausea, Fatigue, |
||||
ACYCLOVIR, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MIRTAZAPINE, |
||||
| 3870 | 25033979 |
CO |
24 | 1 |
Acute kidney injury, Tubulointerstitial nephritis, Intentional product misuse, Drug ineffective, Overdose, |
||||
DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 3871 | 25028517 |
BE |
17 | 1 |
Palpitations, Chills, Abdominal pain, Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3872 | 25028586 |
US |
1 | |
Wrong technique in device usage process, Overdose, Drug ineffective, Product dose omission issue, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL, ALBUTEROL SULFATE, |
||||
| 3873 | 25028600 |
DE |
35 | 2 |
Serotonin syndrome, Tachycardia, Salivary hypersecretion, Confusional state, Hallucination, visual, Delirium, Electrocardiogram QT prolonged, Cerebellar atrophy, Abnormal behaviour, Agitation, Dysarthria, Drug level increased, Restlessness, Overdose, |
||||
MIRTAZAPINE, MIRTAZAPINE, RAMIPRIL, RAMIPRIL, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 3874 | 25028602 |
US |
2 | |
Cardiac valve disease, Seizure, Alopecia, Off label use, Overdose, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, CLOBAZAM, |
||||
| 3875 | 25028744 |
ES |
1 | |
Drug abuse, Non-cardiogenic pulmonary oedema, Intentional product misuse, Drug interaction, Overdose, Toxicity to various agents, Drug dependence, |
||||
ZOLPIDEM TARTRATE, QUETIAPINE FUMARATE, QUETIAPINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALPRAZOLAM, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), MORPHINE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, METHADONE, FENTANYL, FENTANYL, FENTANYL, PROPOFOL, |
||||
| 3876 | 25026181 |
BE |
1 | |
General symptom, Abdominal pain, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3877 | 25026250 |
BE |
19 | 1 |
Alcohol poisoning, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3878 | 25026254 |
FR |
21 | 2 |
Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3879 | 25026259 |
US |
72 | 2 |
Incorrect dose administered, Product dose omission issue, Overdose, Device defective, Wrong technique in product usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 3880 | 25026310 |
US |
41 | 1 |
Acute myocardial infarction, Cardiac ventricular thrombosis, Pericarditis, Hypercoagulation, Overdose, Off label use, |
||||
TESTOSTERONE, TESTOSTERONE,, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 3881 | 25026339 |
BE |
1 | |
Pain, Overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3882 | 25026388 |
US |
2 | |
Incorrect dose administered, Product dose omission issue, Overdose, Device malfunction, Device delivery system issue, Device issue, Needle issue, Product dose omission issue, Nail injury, Visual impairment, Pain, Injection site haemorrhage, Device leakage, |
||||
| 3883 | 25031742 |
36 | 2 | |
Product prescribing error, Overdose, Liquid product physical issue, |
||||
ESTRADIOL VALERATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 3884 | 25022041 |
US |
2 | |
Encephalopathy, Seizure, Cardiac arrest, Circulatory collapse, Shock, Overdose, |
||||
BUPROPION, |
||||
| 3885 | 25022344 |
US |
2 | |
Visual impairment, Hypoacusis, Wrong technique in product usage process, Incorrect dose administered by device, Overdose, Device use issue, Device defective, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 3886 | 25022425 |
PL |
17 | 2 |
Asthenia, Palpitations, Disorientation, Restlessness, Visual impairment, Psychomotor hyperactivity, Blood pressure increased, Blood pressure systolic abnormal, Toxicity to various agents, Overdose, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 3887 | 25022689 |
US |
2 | |
Overdose, |
||||
LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 3888 | 25022695 |
CA |
16 | 2 |
Hallucination, Overdose, Drug abuse, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 3889 | 25022786 |
CA |
36 | 2 |
Foetal death, Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Contraindicated product administered, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Exposure during pregnancy, Fatigue, Fluid retention, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infection, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Upper respiratory tract infection, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ABACAVIR SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, FLUCONAZOLE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, BUPROPION, BUPROPION HYDROBROMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOLUTEGRAVIR SODIUM, ETANERCEPT, FUROSEMIDE, ADALIMUMAB, INFLIXIMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, LAMIVUDINE, LAMIVUDINE ORAL, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, TEMAZEPAM, BUPROPION HYDROCHLORIDE, GABAPENTIN, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, PROGESTERONE, PSYLLIUM HUSK, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, |
||||
| 3890 | 25022822 |
US |
15 | 2 |
Somnolence, Hypotension, Intentional overdose, Overdose, |
||||
TRANEXAMIC ACID, AMLODIPINE, ZOLPIDEM TARTRATE, CLONAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3891 | 25023011 |
BE |
18 | 2 |
Vertigo, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3892 | 25023013 |
BE |
1 | |
General symptom, Abdominal pain, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3893 | 25023017 |
BE |
1 | |
Pain, Product use issue, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3894 | 25023359 |
BE |
2 | |
Malaise, Overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3895 | 25023426 |
CA |
2 | |
Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infusion related reaction, Pain, Joint swelling, Exposure during pregnancy, Intentional product misuse, Off label use, Overdose, Prescribed overdose, Product use issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, ABACAVIR SULFATE, TOCILIZUMAB, TOCILIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3896 | 25023439 |
US |
70 | 2 |
Fluid retention, Overdose, Wrong technique in product usage process, Peripheral swelling, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, FAMOTIDINE, ESCITALOPRAM, ISTRADEFYLLINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 3897 | 25023515 |
ZA |
2 | |
Toxicity to various agents, Non-cardiogenic pulmonary oedema, Overdose, |
||||
AMLODIPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 3898 | 25023529 |
US |
2 | |
Disability, Overdose, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, HYOSCYAMINE SULFATE, ROPINIROLE HYDROCHLORIDE, |
||||
| 3899 | 25023591 |
EU |
70 | 1 |
Gastrointestinal anastomotic leak, Pancytopenia, Hypotension, Diarrhoea, Off label use, Overdose, Underdose, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 3900 | 25023617 |
FR |
2 | 1 |
Altered state of consciousness, Status epilepticus, Bradypnoea, Overdose, Off label use, Intentional product misuse, |
||||
BACLOFEN, VALPROATE SODIUM, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, GABAPENTIN, LEVOCARNITINE, LEVOCARNITINE ORAL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MELATONIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
